DUBLIN--(BUSINESS WIRE)--The "Clinical Trials Sector Scorecard - Q1 2022 Update - Thematic Research" report has been added to ResearchAndMarkets.com's offering.
Many companies included in the Clinical Trials scorecard have announced partnerships in the artificial intelligence (AI) space since December 2021. Pfizer announced partnerships in drug discovery and disease severity scoring, while Thermo Fisher Scientific announced that it was partnering with Medidata Acorn AI to optimize clinical trials.
Merck KGaA is collaborating with Unlearn.AI to accelerate late-stage trials using AI-based digital twins. In virtual care, Takeda posted several jobs relating to virtual trials and initiated trials with virtual components in Q1 2022, and AstraZeneca, Novo Nordisk, and Otsuka were active in digital health deals. Takeda posted several jobs relating to blockchain in Q1 2022, and Dr. Reddy's is partnering with academia to build a new blockchain solution.
Companies Were Also Active in ESG...
Your content is great. However, if any of the content contained herein violates any rights of yours, including those of copyright, please contact us immediately by e-mail at media[@]kissrpr.com.
INN caught up with cryptocurrency investment expert Dan Hoover to review the current landscape and where the market may be heading. The cryptocurrency investment marketplace has gone through severa...